Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1978 Sep;75(9):4573–4576. doi: 10.1073/pnas.75.9.4573

Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice.

R Walter, R F Ritzmann, H N Bhargava, T C Rainbow, L B Flexner, W A Krivoy
PMCID: PMC336159  PMID: 279936

Abstract

The peptide-Z-Pro-D-Leu, injected daily in mice receiving morphine chronically, was found to prevent development of physical dependence as measured by changes in body temperature and body weight due either to abrupt or to naloxone-induced withdrawal. On the other hand, administration of Z-Pro-D-Leu only on the last day of morphine treatment did not alter the overt signs of withdrawal. Daily administration of Z-Pro-D-Leu was also effective in blocking the development of tolerance to the analgesic and the hypothermic effects of subsequent challenge doses of morphine. However, the peptide treatment did not alter the acute effects of a challenge dose of morphine on either analgesia or body temperature. No effects on memory were noted, as evaluated in a one-trial passive avoidance task. Clinical implications of the use of Z-Pro-D-Leu are discussed.

Full text

PDF
4576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhargava H. N. Improved recovery of morphine from biological tissues using siliconized glassware. J Pharm Sci. 1977 Jul;66(7):1044–1045. doi: 10.1002/jps.2600660738. [DOI] [PubMed] [Google Scholar]
  2. Bhargava H. N., Matwyshyn G. A. Brain serotonin turnover and morphine tolerance-dependence induced by multiple injections in the rat. Eur J Pharmacol. 1977 Jul 1;44(1):25–33. doi: 10.1016/0014-2999(77)90112-1. [DOI] [PubMed] [Google Scholar]
  3. Bhargava H. N. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome. Pharmacol Biochem Behav. 1978 Jan;8(1):7–11. doi: 10.1016/0091-3057(78)90115-6. [DOI] [PubMed] [Google Scholar]
  4. COHEN M., KEATS A. S., KRIVOY W., UNGAR G. EFFECT OF ACTINOMYCIN D ON MORPHINE TOLERANCE. Proc Soc Exp Biol Med. 1965 Jun;119:381–384. doi: 10.3181/00379727-119-30187. [DOI] [PubMed] [Google Scholar]
  5. Caldwell J., Sever P. S. The biochemical pharmacology of abused drugs. III. Cannabis, opiates, and synthetic narcotics. Clin Pharmacol Ther. 1974 Dec;16(6):989–1013. doi: 10.1002/cpt1974166989. [DOI] [PubMed] [Google Scholar]
  6. Celis M. E., Taleisnik S., Walter R. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1428–1433. doi: 10.1073/pnas.68.7.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clouet D. H., Iwatsubo K. Mechanisms of tolerance to and dependence on narcotic analgesic drugs. Annu Rev Pharmacol. 1975;15:49–71. doi: 10.1146/annurev.pa.15.040175.000405. [DOI] [PubMed] [Google Scholar]
  8. De Wied D., Gispen W. H. Impaired development of tolerance to morphine analgesia in rats with hereditary diabetes insipidus. Psychopharmacologia. 1976;46(1):27–29. doi: 10.1007/BF00421545. [DOI] [PubMed] [Google Scholar]
  9. De Wied D. Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature. 1971 Jul 2;232(5305):58–60. doi: 10.1038/232058a0. [DOI] [PubMed] [Google Scholar]
  10. HOFMANN K. Preliminary observations relating structure and function in some pituitary hormones. Brookhaven Symp Biol. 1960 Nov;13:184–202. [PubMed] [Google Scholar]
  11. Hoffman P. L., Walter R., Bulat M. An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier. Brain Res. 1977 Feb 11;122(1):87–94. doi: 10.1016/0006-8993(77)90664-3. [DOI] [PubMed] [Google Scholar]
  12. Koida M., Walter R. Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J Biol Chem. 1976 Dec 10;251(23):7593–7599. [PubMed] [Google Scholar]
  13. Krivoy W. A., Zimmermann E., Lande S. Facilitation of development of resistance to morphine analgesia by desglycinamide9-lysine vasopressin. Proc Natl Acad Sci U S A. 1974 May;71(5):1852–1856. doi: 10.1073/pnas.71.5.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lande S., Flexner J. B., Flexner L. B. Effect of corticotropin and desglycinamide 9 -lysine vasopressin on suppression of memory by puromycin. Proc Natl Acad Sci U S A. 1972 Mar;69(3):558–560. doi: 10.1073/pnas.69.3.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Legros J. J., Gilot P., Seron X., Claessens J., Adam A., Moeglen J. M., Audibert A., Berchier P. Influence of vasopressin on learning and memory. Lancet. 1978 Jan 7;1(8054):41–42. doi: 10.1016/s0140-6736(78)90386-0. [DOI] [PubMed] [Google Scholar]
  16. Oliveros J. C., Jandali M. K., Timsit-Berthier M., Remy R., Benghezal A., Audibert A., Moeglen J. M. Vasopressin in amnesia. Lancet. 1978 Jan 7;1(8054):42–42. doi: 10.1016/s0140-6736(78)90387-2. [DOI] [PubMed] [Google Scholar]
  17. Rainbow T. C., Adler J. E., Flexner L. B. Comparison in mice of the amnestic effects of cycloheximide and 6-hydroxydopamine in a one-trial passive avoidance task. Pharmacol Biochem Behav. 1976 Mar;4(3):347–349. doi: 10.1016/0091-3057(76)90254-9. [DOI] [PubMed] [Google Scholar]
  18. Ritzmann R., Tabakoff B. Is serotonin or are its metabolites responsible for induction of hypothermia? Experientia. 1976 Mar 15;32(3):334–336. doi: 10.1007/BF01940823. [DOI] [PubMed] [Google Scholar]
  19. Walter P. Indentification of sites in oxytocin involved in uterine receptor recognition and activation. Fed Proc. 1977 May;36(6):1872–1878. [PubMed] [Google Scholar]
  20. Walter R., Hoffman P. L., Flexner J. B., Flexner L. B. Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia. Proc Natl Acad Sci U S A. 1975 Oct;72(10):4180–4184. doi: 10.1073/pnas.72.10.4180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walter R., van Ree J. M., de Wied D. Modification of conditioned behavior of rats by neurohypophyseal hormones and analogues. Proc Natl Acad Sci U S A. 1978 May;75(5):2493–2496. doi: 10.1073/pnas.75.5.2493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Wied D. Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments. Life Sci. 1976 Sep 1;19(5):685–690. doi: 10.1016/0024-3205(76)90165-x. [DOI] [PubMed] [Google Scholar]
  23. de Wied D., Greven H. M., Lande S., Witter A. Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion. Br J Pharmacol. 1972 May;45(1):118–122. doi: 10.1111/j.1476-5381.1972.tb09582.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. van Ree J. M., de Wied D. Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence. Life Sci. 1976 Nov 1;19(9):1331–1339. doi: 10.1016/0024-3205(76)90430-6. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES